HCA analyst estimates
HCA Healthcare (HCA) analyst ratings, the average price target and its range, and every firm's latest call.
HCA analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 29, 2026 | Barclays | HCA Healthcare price target raised to $401 from $387 at Barclays | $401.00 |
| Oct 28, 2026 | Mizuho Securities | HCA Healthcare price target raised to $495 from $475 at Mizuho | $495.00 |
| Oct 28, 2026 | KeyBanc | HCA Healthcare price target raised to $490 from $435 at KeyBanc | $490.00 |
| Oct 7, 2026 | RBC Capital | HCA Healthcare price target raised to $496 from $435 at RBC Capital | $496.00 |
| Sep 22, 2026 | BMO Capital | HCA Healthcare initiated with an Outperform at BMO Capital | $495.00 |
| Jul 28, 2026 | Goldman Sachs | HCA Healthcare price target lowered to $485 from $558 at Goldman Sachs | $485.00 |
| Jul 27, 2026 | KeyBanc | HCA Healthcare price target lowered to $435 from $475 at KeyBanc | $435.00 |
| Jul 27, 2026 | Barclays | HCA Healthcare price target lowered to $387 from $402 at Barclays | $387.00 |
| Jul 27, 2026 | Robert W. Baird | HCA Healthcare price target lowered to $393 from $396 at Baird | $393.00 |
| Jul 27, 2026 | Oppenheimer | HCA Healthcare price target lowered to $485 from $520 at Oppenheimer | $485.00 |
| Jul 27, 2026 | Morgan Stanley | HCA Healthcare price target lowered to $380 from $425 at Morgan Stanley | $380.00 |
| Jul 27, 2026 | Deutsche Bank | HCA Healthcare price target lowered to $476 from $540 at Deutsche Bank | $476.00 |
| Jul 27, 2026 | UBS | HCA Healthcare price target lowered to $579 from $635 at UBS | $579.00 |
| Jul 20, 2026 | Wells Fargo | HCA Healthcare price target lowered to $369 from $428 at Wells Fargo | $369.00 |
| Jul 16, 2026 | Barclays | HCA Healthcare price target lowered to $402 from $427 at Barclays | $402.00 |
- 22 firms rate HCA: 15 buy, 6 hold, 1 sell.
- The average price target is $462.00 from 12 analysts, from $369.00 to $579.00.
Updated 2026-11-02 17:53 UTC